CPDD Ongoing Updates and Resources
Related to Executive OrdersCPDD Ongoing Updates and Resources
Related to Executive OrdersTHE LATEST NEWS AND STATEMENTS
Letter on Dosing Limits for Cannabis
Dr. Ryan Vandry, a member of CPDD, has released new, science-driven recommendations to help guide federal policy on hemp-derived cannabinoid products, emphasizing a balanced approach that protects public health while preserving access to beneficial therapies. Developed in concert with leading scientists in the field of cannabis research and pharmacology, the recommendations address growing concerns around unregulated, high-dose intoxicating cannabinoid products while recognizing the important...
2026 CPDD Hill Informational Flyers
CPDD’s 2026 informational flyers and white papers are designed to clearly communicate key priorities in SUD and addiction science and policy. These resources provide an accessible overview of current research efforts, critical funding needs, particularly for NIDA, and the broader policy landscape impacting substance use prevention, treatment, and recovery. They also include key data points, legislative updates, and actionable steps to help stakeholders effectively engage with policymakers and...
CPDD Advocacy Day 2026: Science in Action on Capitol Hill
This year, 32 College members from 17 states met with congressional offices to underscore a unified message: strong federal support for substance use and addiction research is essential to improving public health nationwide. The conversations reflected both urgency and opportunity, highlighting the key priorities CPDD members find foundational in their research, field, and community. Sustaining Strong Federal Research Funding CPDD members thanked their Congressional representatives for their...
Advocacy 101 Workshop
The CPDD Public Policy Committee will host an Advocacy 101 Workshop at this year’s 88th Annual Scientific Meeting, offering attendees a practical introduction to effective civic engagement and advocacy in the field of substance use research and policy. This session is designed for newcomers looking to strengthen their ability to communicate with policymakers, translate science into impact, and advance evidence-based solutions. Join the conversation and register for the Annual Meeting...
EXECUTIVE ORDERS, LEGISLATIVE RESOURCES AND GOVENMENT MEMOS
SEARCHABLE OPM MEMOS DATABASE
CONSISTENTLY UPDATED
04.24.2026 SAMHSA MOUD Guidance
04.18.2026 ACCELERATING MEDICAL TREATMENTS FOR SERIOUS MENTAL ILLNESS
CONSOLIDATED OVERVIEW OF NIH FY 2027 BUDGET
04.16.2026 NIH INSTITUTE AND CENTER BUDGET SUBMISSIONS
04.01.2026 NIH RESEARCHERS DISCOVER PAIN-RELIVEING DRUG WITH MINIMAL ADDICTIVE PROPERTIES
03.18.2026 FDA RELEASES DRAFT GUIDANCE ON ALTERNATIVES TO ANIMAL TESTING IN DRUG DEVELOPMENT
01.29.2026 ADDRESSING ADDICTION THROUGH THE GREAT AMERICAN RECOVERY INITIATIVE
12.18.2025 INCREASING MEDICAL MARIJUANA AND CANNABIDIOL RESEARCH
12.15.25 DESIGNATING FENTANYL AS A WEAPON OF MASS DESTRUCTION
8.8.25 IMPROVING OVERSIGHT OF FEDERAL GRANTMAKING
How Does the NIH Initiative to Prioritize Human-Based Research Affect Research Proposing the Use of Laboratory Animals?
FDA-NIH Workshop Reducing Animal Testing
7.9.2025
NIH RESCINDS, AT LEAST FOR NOW, ITS DEI BAN ON GRANTS TO INSTITUTIONS 06.10.2025
HELP Committee Minority Report 05.13.2025
SCIENTISTS ARE PUSHING TO GET THEIR GRANTS REINSTATED - AND SOME ARE WINNING ARTICLE
05.20.2025
PRESIDENT TRUMP'S FY26 DISCRETIONARY FUNDING REQUEST
THE BETHESDA DECLARATION: A CALL FOR NIH AND HHS LEADERSHIP TO DELIVER ON PROMISES OF ACADEMIC FREEDOM AND SCIENTIFIC EXCELLENCE 06.10.2025
LETTER ON DISCRETIONARY FUNDING LEVELS FOR FY26
05.02.2025
HHS REORGANIZATION MEMO
03.27.2025
INDIRECT COST LOSS BY CONGRESSIONAL DISTRICT
03.17.2025
SENATE CONGRESSIONAL FORUM HIGHLIGHT VIDEO
03.26.2025
ADDICTION SCIENCE DEFENSE NETWORK STATEMENT OF CONCERN
NIH CENTRALIZES PEER REVIEW TO IMPROVE EFFICIENCY AND STRENGTHEN INTEGRITY
03.06.2025
REFORMING THE NATIONAL INSTITUTES OF HEALTH FRAMEWORK FOR DISCUSSION
03.06.2025
INDIRECT COST RATE PPRELIMINARY INJUNCTION GRANTED
03.05.2025
SPARE ACT
2025 APPROPRIATIONS BILL
03.05.2025
SCIENTISTS WARN OF LONG-TERM DAMAGE AS TRUMP'S ORDERS SLOW RESEARCH
RFK JR. MOVES TO ELIMINATE PUBLIC COMMENT ON HHS DECISIONS
RFK JR. ROLLS BACK TRANSPARENCY POLICY ON MEDICAID AND NIH CHANGES
FAQ ABOUT FACILITIES AND ADMINISTRATIVE (F&A) COSTS OF FEDERALLY SPONSORED RESEARCH
02.10.2025
ASSOCIATION OF AMERICAN UNIVERSITIES BREAKING DOWN THE COSTS OF FEDERAL RESEARCH AT UNIVERSITIES
EXPLANATION OF INDIRECTS
IMAGE
UMR: NIH ROLE IN SUSTAINING THE US ECONOMY
2024 UPDATE
COURT ORDER TO RESTORE PUBLIC HEALTH WEBSITES (CDC, FDA, ETC.)
02.11.2025
RESTRAINING ORDER TO IDC CUTS TO THE EDUCATIONAL COMMUNITY
02.11.2025
NIH INDIRECT COST RATE IMPACT BY STATE
02.09.2025
AAMC COURT FILING
02.07.2025
NOTICE OF TEMPORARY RESTRAINING ORDER IN NEW YORK ET AL. V. TRUMP
01.31.2025
IMPLEMENTING THE PRESIDENT'S "DEPARTMENT OF GOVERNMENT EFFECIENCY" WORKFORCE OPTIMIZATION INITIATIVE
02.11.2025
RESCISSION OF TEMPORARY PAUSE OF AGENCY GRANT, LOAN, AND OTHER FINANCIAL ASSISTANCE PROGRAMS MEMO
01.29.2025
SUPPLEMENTAL GUIDANCE TO THE 2024 NIH GRANT POLICY STATEMENT: INDIRECT COST RATES
02.07.2025
TEMPORARY INJUNCTION TO THE 2024 NIH GRANT POLICY STATEMENT: INDIRECT COST RATES
02.07.2025
COURT FILING TO THE 2024 NIH GRANT POLICY STATEMENT: INDIRECT COST RATES
02.07.2025
DEFERRED RESIGNATION EMAIL TO FEDERAL EMPLOYEES
01.28.2025
NATIONAL SCIENCE COUNCIL IMPLEMENTATION OF RECENT EXECUTIVE ORDERS
01.29.2025
FRIENDS OF NIDA - INDIRECT COSTS SIGN ON LETTER
02.21.2025
OTHER ORGANIZATIONAL RESOURCES AND LETTERS
JAMA COMMENTARY ON FIRST 100 DAYS & CHANGES TO ADDICTION POLICY
How Does the NIH Initiative to Prioritize Human-Based Research Affect Research Proposing the Use of Laboratory Animals? 7.18.25